It's hard enough to own a chemical company today, with the volatility in input costs and the wobbly state of the global economy. Factor in a sizable sales exposure to Europe, and it's not exactly surprising that Rockwood Holdings (NYSE:ROC) is off its best levels. Nevertheless, with solid exposure to growth markets like lithium and advanced ceramics, and management's plans to monetize non-core assets actively, these shares may be worth a look for investors that are more aggressive.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

Titanium About to Go Bye-Bye?
Earlier this year, management confirmed what many investors and analysts had been speculating on for some time - the company is going to look to dispose of its titanium dioxide business. While the company had looked to sell this business (which it co-owns in a JV structure with Kemira), it doesn't look like there was much demand. As a result, the company is going to pursue an IPO in the second half of this year.

Rockwood's titanium dioxide business isn't a run-of-the-mill commodity business. Unlike major TiO2 producers like DuPont (NYSE:DD), Tronox (OTCBB:TROX) and Huntsman (NYSE:HUN), Rockwood has focused more of its attention on anatase TiO2 products - a version that can be used in higher-value applications like synthetic fibers, food and pharmaceuticals.

While the details aren't finalized, this transaction should allow Rockwood to offload some of its debt onto the new public company, as well as using IPO proceeds, dividends and/or future additional share sales to create additional capital. Moreover, with the TiO2 market still on the way back, there is a reasonable chance that the company can see a good price in this transaction.

SEE: How An IPO Is Valued

Growth Opportunities in Ceramics
Advanced ceramics have long been a very profitable business for Rockwood, but it's also a business with some meaningful growth potential. Right now, Rockwood is the only supplier of ceramic materials for FDA-approved ceramic implants sold by companies like Stryker (NYSE:SYK) and Johnson & Johnson (NYSE:JNJ). The company is also working on ceramic materials for knee implants, and the knee implant market is considerably larger than the hip market.

Lithium a Growth Opportunity ... for Now
One of the most common stories repeated about Rockwood is its large share of the lithium market. It's a valid point; Rockwood has low-cost lithium assets in Chile and along with Sociedad Quimica y Minera de Chile (NYSE:SQM), the companies control much of the lithium market.

While lithium has a wide range of applications across many industry categories, the big story on lithium is its value in batteries. Whether it's the batteries that power Apple (Nasdaq:AAPL) phones and tablets or the batteries that power Tesla Motors (Nasdaq:TSLA) roadsters, lithium features prominently in advanced batteries today. Assuming that battery-powered, hybrid and stop-start autos continue to catch on with customers, lithium demand should remain solid.

It's worth asking if the long-term picture is so bright. I don't pretend to be an engineer or materials scientist, but I question whether lithium-based batteries are really the long-term solution to advanced battery needs. While lithium batteries are good enough for full hybrids like the Toyota (NYSE:TM) Prius or plug-in hybrids like the Fisker Karma, I'm not sure they're the long-term answer to fully electric vehicles. Nevertheless, they're the best that's available today and there's no reason to think that demand is going to fall off soon.

SEE: Clean Or Green Technology Investing

The Bottom Line
Given that a lot of Rockwood's business is still in commodity chemical/specialty chemical products, I don't believe that the company deserves the same forward EBITDA multiple as a company like DuPont. That said, even at six times or 6.5 times 2012 EBITDA, Rockwood looks undervalued today. While a further slowdown in the global economy is clearly a risk factor this company, Rockwood seems to be trying to orient itself more towards higher-value, defensible markets with more interesting long-term prospects. Accordingly, and in combination with the valuation, this is a name worth further due diligence today.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing

    What Investors Need to Know About Returns in 2016

    Last year wasn’t a great one for investors seeking solid returns, so here are three things we believe all investors need to know about returns in 2016.
  3. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  4. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  5. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  6. Stock Analysis

    The Top 5 Micro Cap Alternative Energy Stocks for 2016 (AMSC, SLTD)

    Follow a cautious approach when purchasing micro-cap stocks in the alternative energy sector. Learn about five alternative energy micro-caps worth considering.
  7. Stock Analysis

    Tech Stocks Vs. Financial Stocks in 2016

    Consider the arguments for allocating more of your investment portfolio to either the technology sector or the financial sector for 2016.
  8. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  9. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  10. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center